Walgreens Boots Alliance Inc (WBA) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lowered its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 26.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,435,153 shares of the pharmacy operator’s stock after selling 884,467 shares during the period. Massachusetts Financial Services Co. MA owned 0.26% of Walgreens Boots Alliance worth $177,523,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of WBA. Thomasville National Bank acquired a new position in shares of Walgreens Boots Alliance during the third quarter worth $233,000. Balasa Dinverno & Foltz LLC lifted its holdings in shares of Walgreens Boots Alliance by 10.9% during the third quarter. Balasa Dinverno & Foltz LLC now owns 10,868 shares of the pharmacy operator’s stock worth $792,000 after purchasing an additional 1,071 shares during the period. Dearborn Partners LLC lifted its holdings in shares of Walgreens Boots Alliance by 2.2% during the third quarter. Dearborn Partners LLC now owns 221,799 shares of the pharmacy operator’s stock worth $16,169,000 after purchasing an additional 4,839 shares during the period. Capital Advisors Ltd. LLC lifted its holdings in shares of Walgreens Boots Alliance by 1,150.3% during the third quarter. Capital Advisors Ltd. LLC now owns 2,063 shares of the pharmacy operator’s stock worth $150,000 after purchasing an additional 1,898 shares during the period. Finally, AMG National Trust Bank lifted its holdings in shares of Walgreens Boots Alliance by 3.4% during the third quarter. AMG National Trust Bank now owns 24,726 shares of the pharmacy operator’s stock worth $1,803,000 after purchasing an additional 824 shares during the period. Hedge funds and other institutional investors own 64.83% of the company’s stock.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total value of $180,548.64. Following the transaction, the director now directly owns 10,943 shares in the company, valued at $722,128.57. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 14.80% of the stock is owned by insiders.



Walgreens Boots Alliance stock opened at $76.23 on Monday. Walgreens Boots Alliance Inc has a fifty-two week low of $59.07 and a fifty-two week high of $80.68. The stock has a market cap of $72.35 billion, a P/E ratio of 12.66, a PEG ratio of 1.19 and a beta of 1.04. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.45 by $0.03. The firm had revenue of $33.44 billion for the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. As a group, research analysts anticipate that Walgreens Boots Alliance Inc will post 6.53 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date is Thursday, November 8th. Walgreens Boots Alliance’s payout ratio is 29.24%.

A number of equities analysts have recently commented on the stock. Pivotal Research lifted their price target on shares of Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a report on Monday, October 15th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a report on Saturday, October 13th. Barclays lifted their price target on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a report on Friday, October 12th. Robert W. Baird lifted their price target on shares of Walgreens Boots Alliance from $69.00 to $71.00 and gave the stock a “neutral” rating in a report on Friday, October 12th. Finally, Citigroup lifted their target price on shares of Walgreens Boots Alliance from $69.00 to $76.00 and gave the stock a “neutral” rating in a research note on Friday, October 12th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $78.22.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Further Reading: Growth Stocks

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply